Question

A 62-year-old with T2D and prior MI has A1C 7.4% on metformin. eGFR 70 mL/min/1.73 m², BMI 31 kg/m². Which addition best addresses cardiovascular risk reduction?

Accepted Answer

GLP-1 receptor agonist with proven CV benefit (e.g., semaglutide)

Answer

Basal insulin

Answer

Sulfonylurea

Answer

DPP-4 inhibitor

Answer

Pioglitazone

Practice question

A 62-year-old with T2D and prior MI has A1C 7.4% on metformin. eGFR 70 mL/min/1.73 m², BMI 31 kg/m². Which addition best addresses cardiovascular risk reduction?